• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FAM207BP,一个假基因衍生的长非编码 RNA,促进肺腺癌细胞的增殖、迁移和侵袭,并作为一个免疫相关的预后因素。

FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.

机构信息

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.

出版信息

Life Sci. 2021 Mar 1;268:119022. doi: 10.1016/j.lfs.2021.119022. Epub 2021 Jan 9.

DOI:10.1016/j.lfs.2021.119022
PMID:33434533
Abstract

AIMS

This study aimed to characterize the functions of pseudogene-derived long non-coding RNA (lncRNA) FAM207BP in lung adenocarcinoma (LUAD).

MATERIALS AND METHODS

Through the Cancer Genome Atlas (TCGA)-Genotype Tissue Expression (GTEx) database, FAM207BP expression was detected in LUAD and normal tissues. Overall survival (OS) and disease-free survival (DFS) analysis was presented using log-rank test or univariate Cox regression analysis. The relationships between FAM207BP expression and clinical features were analyzed. FAM207BP expression was validated in LUAD tissues and cells using RT-qPCR. Cell viability of LUAD cells was evaluated after silencing or overexpressing FAM207BP. Furthermore, migrated and invasive abilities were examined by Transwell and scratch assays. The correlation between FAM207BP expression and the immune infiltration levels was analyzed. Gene Set Enrichment Analysis (GSEA) was performed for high- and low-expression of FAM207BP using C2 collection in the Molecular Signatures Database (MSigDB) database.

KEY FINDINGS

FAM207BP expression was distinctly higher in LUAD than normal tissues. Patients with its high expression indicated worse OS and DFS time. FAM207BP expression was significantly related to gender. RT-qPCR results confirmed that FAM207BP was significantly highly expressed in LUAD tissues and cells. Knockdown of FAM207BP distinctly suppressed cellular viability, migration and invasion for LUAD cells. Also, its expression was negatively related to B cell infiltration levels. GSEA results indicated that high FAM207BP expression was involved in regulation of gene expression. Its low expression was related to immune response.

SIGNIFICANCE

Pseudogene-derived lncRNA FAM207BP could induce proliferation and migration of LUAD cells, which could act as an immune-related prognostic factor.

摘要

目的

本研究旨在探讨假基因衍生的长链非编码 RNA(lncRNA) FAM207BP 在肺腺癌(LUAD)中的功能。

材料和方法

通过癌症基因组图谱(TCGA)-基因组织表达(GTEx)数据库,检测 LUAD 和正常组织中 FAM207BP 的表达。使用对数秩检验或单因素 Cox 回归分析进行总生存(OS)和无病生存(DFS)分析。分析 FAM207BP 表达与临床特征的关系。采用 RT-qPCR 验证 FAM207BP 在 LUAD 组织和细胞中的表达。沉默或过表达 FAM207BP 后,评估 LUAD 细胞的活力。通过 Transwell 和划痕实验检测迁移和侵袭能力。分析 FAM207BP 表达与免疫浸润水平的相关性。使用分子特征数据库(MSigDB)中的 C2 集合,对 FAM207BP 高表达和低表达进行基因集富集分析(GSEA)。

主要发现

FAM207BP 在 LUAD 中的表达明显高于正常组织。高表达的患者 OS 和 DFS 时间更差。FAM207BP 的表达与性别显著相关。RT-qPCR 结果证实 FAM207BP 在 LUAD 组织和细胞中显著高表达。沉默 FAM207BP 明显抑制 LUAD 细胞的细胞活力、迁移和侵袭。此外,其表达与 B 细胞浸润水平呈负相关。GSEA 结果表明,高 FAM207BP 表达参与基因表达的调控。低表达与免疫反应有关。

意义

假基因衍生的 lncRNA FAM207BP 可诱导 LUAD 细胞的增殖和迁移,可作为与免疫相关的预后因素。

相似文献

1
FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.FAM207BP,一个假基因衍生的长非编码 RNA,促进肺腺癌细胞的增殖、迁移和侵袭,并作为一个免疫相关的预后因素。
Life Sci. 2021 Mar 1;268:119022. doi: 10.1016/j.lfs.2021.119022. Epub 2021 Jan 9.
2
Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.新型基质/免疫评分相关 P2RY12 在肺腺癌微环境中的预后价值及免疫浸润分析。
Int Immunopharmacol. 2021 Sep;98:107734. doi: 10.1016/j.intimp.2021.107734. Epub 2021 Jun 25.
3
A methylation-related lncRNA-based prediction model in lung adenocarcinomas.基于甲基化相关长链非编码 RNA 的肺腺癌预测模型。
Clin Respir J. 2024 Aug;18(8):e13753. doi: 10.1111/crj.13753.
4
Characterization of an endoplasmic reticulum stress-associated lncRNA prognostic signature and the tumor-suppressive role of RP11-295G20.2 knockdown in lung adenocarcinoma.内质网应激相关长链非编码 RNA 预后特征分析及 RP11-295G20.2 敲低在肺腺癌中的抑瘤作用。
Sci Rep. 2024 May 29;14(1):12283. doi: 10.1038/s41598-024-62836-z.
5
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
6
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.SEC61G 在肺腺癌中的预后价值:基于生物信息学和体外验证的综合研究。
BMC Cancer. 2021 Nov 13;21(1):1216. doi: 10.1186/s12885-021-08957-4.
7
Prognostic value of long noncoding RNA LINC00924 in lung adenocarcinoma and its regulatory effect on tumor progression.长链非编码 RNA LINC00924 在肺腺癌中的预后价值及其对肿瘤进展的调控作用。
Histol Histopathol. 2024 May;39(5):595-602. doi: 10.14670/HH-18-642. Epub 2023 Jun 26.
8
Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma.二硫键相关 lncRNAs 特征预测肺腺癌的预后和免疫治疗效果。
Aging (Albany NY). 2024 Jun 10;16(11):9972-9989. doi: 10.18632/aging.205911.
9
The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration.EMG1 在肺腺癌进展中的作用:对预后和免疫细胞浸润的影响。
Int Immunopharmacol. 2024 Sep 10;138:112553. doi: 10.1016/j.intimp.2024.112553. Epub 2024 Jun 28.
10
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.

引用本文的文献

1
The role of B cell immunity in lung adenocarcinoma.B细胞免疫在肺腺癌中的作用。
Genes Immun. 2025 May 13. doi: 10.1038/s41435-025-00331-9.
2
KIS, a target of SOX4, regulates the ID1-mediated enhancement of β-catenin to facilitate lung adenocarcinoma cell proliferation and metastasis.KIS 是 SOX4 的靶标,调节 ID1 介导的β-catenin 增强,促进肺腺癌细胞增殖和转移。
J Cancer Res Clin Oncol. 2024 Jul 25;150(7):366. doi: 10.1007/s00432-024-05853-9.
3
Screening of Immune-related lncRNAs in Lung Adenocarcinoma and Establishing a Survival Prognostic Risk Prediction Model.
肺腺癌免疫相关 lncRNAs 的筛选及生存预后风险预测模型的建立。
Comb Chem High Throughput Screen. 2024;27(8):1175-1190. doi: 10.2174/1386207326666230913120523.
4
Characterization of cuproptosis-related lncRNA landscape for predicting the prognosis and aiding immunotherapy in lung adenocarcinoma patients.用于预测肺腺癌患者预后及辅助免疫治疗的铜死亡相关长链非编码RNA图谱特征分析
Am J Cancer Res. 2023 Mar 15;13(3):778-801. eCollection 2023.
5
The double homeobox a pseudogene 8 accelerates cell proliferation, migration, and invasion in colon cancer.双同源盒A假基因8促进结肠癌细胞的增殖、迁移和侵袭。
Bioengineered. 2022 Apr;13(4):8164-8173. doi: 10.1080/21655979.2022.2053802.
6
Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD.构建免疫相关 lncRNA 特征作为 LUAD 的新型预后生物标志物。
Aging (Albany NY). 2021 Aug 26;13(16):20684-20697. doi: 10.18632/aging.203455.